Commonly used antibiotic shows promise for combating Zika infections
National Institutes of Health (NIH) sent this bulletin at 11/24/2020 01:30 PM ESTHaving trouble viewing this email? View it as a Web page.
You are receiving this message because you are subscribed to News Releases for National Institutes of Health (NIH).
11/24/2020 12:15 PM EST
NIH preclinical study suggests FDA-approved tetracycline-based antibiotics may slow infection and reduce neurological problems.